Campaign Materials, Page 6 | Buxton Helmsley

Now OfferingAn interest in the strategy, or in the business that runs it.Minimum close January 29, 2027.Request Information→Now OfferingAn interest in the strategy, or in the business that runs it.An interest in the strategy.Request info →→

Now Offering

An interest in the strategy,
or in the business that runs it.

Limited partnership interests in the fund, and common stock in Buxton Helmsley, Inc. Open to accredited investors only.

View The Offering→

Company

OverviewThe firm’s mandate, its history, and how it is structured.
LeadershipThe board of directors and executive management.
HistoryThe Buxton Helmsley name from 2014 to today.
Charitable FoundationThe firm’s philanthropic arm, launching in 2027.

Our Business

Our ProcessSourcing, diligence, portfolio construction, and action.
Active FundThe current fund, its terms, and its administration.

Impact

Investor AdvocacyConstructive engagement, and escalation when required.
CampaignsCampaigns under the Buxton Helmsley name, with outcomes.

Advisory

OverviewTransactions, turnarounds, governance, and investigations, built on forensic analysis.
Expert Advisory BoardSpecialists for preventing a crisis, and for steadying a company in one.
IndependenceThe conflict rules that apply to every engagement.
Terms of EngagementWho undertakes the work, and on what terms.

News

Press ReleasesStatements issued by the firm.
Media CoverageThe firm and its campaigns in the press.
Media KitBoilerplate, fact sheet, logos, and the media contact.

Oversight

GovernanceHow the firm is overseen and held to account.
Operations & ControlsIndependent records, two-person approvals, and compliance.
Strategic PartnersAuditor, administrator, prime brokers, and counsel.

Who We Serve

Institutional InvestorsMandates for institutions and their advisers.
Family OfficesSingle and multi-family office relationships.
Private InvestorsAccredited individuals and qualified purchasers.
EligibilityWho may invest, and the standards that apply.

Who We Work With

Boards and CommitteesAn outside reading of the company’s record for its committees.
Management TeamsPlans, disclosures, and transactions tested as the market will test them.
Private Equity and LendersReported results tested before a transaction closes or a loan is made.
Litigation CounselReported figures rebuilt from the record for matters in dispute.

Resources

InsightsResearch on governance, disclosure, and market structure.

Placement Agents Careers Offices

New York07:54PM
London12:54AM
Hong Kong08:54AM

News & Insights

The latest on investor advocacy.

Search the archive

All188 Insights45 Press Releases25 Media Coverage25 Campaign Materials93

Newest first

DateTitleLength

May 2023

April 2023

March 2023

July 2022

May 2022

February 2022

January 2022

Showing 66–78 of 93

1 5 6 7 8 Next

The Buxton Helmsley Brief.

Research, campaign updates, and market commentary, delivered as they publish.

New content typically once to twice per week. No marketing; unsubscribe at any time.

An alternative asset manager and corporate advisory firm with global impact, anchored in New York.

The Firm
Asset Management
Advisory
News & Insights
Investors
Placement Agents
Careers
Offices

New York

1185 Avenue of the Americas, Floor 3

New York, NY 10036-2600

+1 (212) 561-5540

Investor Relationsir@buxtonhelmsley.com
Mediamedia@buxtonhelmsley.com
Generalgeneral@buxtonhelmsley.com
Advisoryadvisory@buxtonhelmsley.com

News & Insights

May 2023

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: Continued Evidentially False Financial Statements – Mallinckrodt Plc.”) External

April 2023

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: March 17, 2023, Investigation Report – Mallinckrodt Plc.”) External

March 2023

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: Post-Reorganization Financial Disclosure Violation Notice – Mallinckrodt Plc.”) External

Letter to U.S. Senators Elizabeth Warren and Sheldon Whitehouse (Subject: “Re: Mallinckrodt Plc. (NYSE: MNK) - $2.3 Billion Intangible Asset Depreciation Concealment – Intervention Urgently Required)” External

July 2022

Final Public Letter to Endo International plc. External

May 2022

Initial Public Letter to Endo International plc. Shareholders and Creditors External

Private Letters to Endo International plc. - Publicly Released May 13, 2022 External

February 2022

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: February 9, 2022, Letter from Mallinckrodt Plc. to The Buxton Helmsley Group, Inc.”) External

January 2022

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: Updated Notice of The Buxton Helmsley Group, Inc.’s Significant Interest in the Ordinary Shares of Mallinckrodt Plc.”) External

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: Notice of Second Violation Instance of the Companies Act of 2014, § 216”) External

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: The Buxton Helmsley Group, Inc.’s Notice of Significant Ownership of Ordinary Shares - Mallinckrodt Plc.”) External

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: Notice of Additional Statutory Breach (Failure to Cooperate with Request for Production of Registers and Meeting Minutes, Pursuant to Companies Act of 2014, § 216)”) External

Letter to Mallinckrodt Plc. Board of Directors (Subject: “Re: Letter Response - ‘Notice under Section 1062 Companies Act 2014’”) External